SPLASH BEVERAGE GROUP INC (SBEV)
AMEXConsumer StaplesBeverages - Wineries & DistilleriesSnapshot 2026-11-05
$0.31-25.92%
Close 2026-08-28 · 1-day change
AMEXConsumer StaplesBeverages - Wineries & DistilleriesSnapshot 2026-11-05
QuarterlyIQ Insights · SBEV
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 386.8% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name has been missing across recent quarters and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 1 industry peers · Company calendar date is not available
SBEV — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-08-28
Unregistered Sales of Equity Securities. On August 25, 2026, Endovia Health Sciences, Inc. (the “Company”) sold and issued a total of 510,951 shares of common stock pursuant to that certain Securities Purchase Agreement dated September 19, 2025 with C/M Capital Master Fund, LP as purchaser (the “ELOC Agreement”) for total gross proceeds of $107,610.62. The ELOC Agreement was previously disclosed in the Company’s Current Report on Form 8-K filed on September 25, 2025. To the extent such sales…
Why it matters: The company disclosed an equity listing issue and a going-concern warning. NYSE approval would give it time to work on compliance.
Watch forNYSE American accepts the plan and grants a cure period through January 29, 2027.
Also watch forNYSE American rejects the plan or starts steps to delist the shares.
Why it matters: The first-half loss from continuing operations fell about 64% year over year. More cuts could ease the strain on cash as the company builds its new business.
Supportive ifThe next six-month report shows a loss from continuing operations below $4 million.
Worry ifThe next six-month report shows a loss from continuing operations at or above $4 million.
Why it matters: FDA feedback can clarify the path for testing CannEpil in people. A clear path would move this new program forward.
Supportive ifThe company files that FDA held the requested meeting and gave a clear next-step plan for CannEpil.
Worry ifThe FDA declines the meeting, asks for major new work, or the company reports that it did not submit the request.
Why it matters: The company raised $107,610.62 by issuing 510,951 shares in August. More share sales could add to dilution while losses continue.
Worry ifA later filing reports another share issue under the equity line for cash proceeds.
Less concerning ifA later filing reports no new equity-line shares. It names another source of operating funds.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$558 on $10,000 · ±5.6% | How much price usually moves either way. |
| Bad day | $1,655 loss on $10,000 · 16.5% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,695 loss on $10,000 · 97.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.